(HealthDay News) -- An experimental compound called HDACi 4b reversed Huntington's disease symptoms in mice genetically altered to develop the disease, say researchers at the Scripps Research Institute in California.

Huntington's is an inherited neurological disease that affects people's movement and thinking ability. There is no cure or treatment that can reverse or slow progression of the physical and mental deficits caused by the disease.

By Steven Reinberg
EmpowHer's HealthDay Reporter

WEDNESDAY, June 25 (HealthDay News) -- People taking dopamine agonists to treat Parkinson's disease are at risk for impulse-control disorders such as compulsive gambling, buying and sexual behavior, University of Pennsylvania researchers report.

In fact, people taking these particular medications are three times more likely to engage in these behaviors compared with Parkinson's patients not taking these drugs.

The connection is not entirely new.

THURSDAY, June 12 (HealthDay News) -- High doses of a drug used to fight cancer may reduce disease activity and disability in people with aggressive multiple sclerosis, results of a small trial suggest.

In relapsing-remitting MS, the most common type of the disease, patients experience periods of symptoms followed by stretches of symptom-free remission when they used the immunosuppressant drug cyclophosphamide.

MONDAY, June 2 (HealthDay News) -- A new drug may help people with Parkinson's disease combat the tics, spasms and tremors they experience when their main medications wear off, a new study suggests.

MONDAY, May 12 (HealthDay News) -- A few millimeters can make a huge difference for Parkinson's patients treated with electrodes surgically implanted in the brain, a new study finds.